TEVA FY 2025 Earnings — Teva Pharmaceutical Industries Limited Revenue & Financial Results | Market Cap Arena

TEVATeva Pharmaceutical Industries Limited

$37B

FY 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$17.3B+4.3% YoY

Gross Profit

$8.9B51.8% margin

Operating Income

$2.2B12.5% margin

Net Income

$1.4B8.2% margin

EPS (Diluted)

$1.20

Cash Flow

Operating Cash Flow

$1.6B

Free Cash Flow

$1.1B

Stock-Based Comp.

$157M

Balance Sheet

Total Assets

$40.7B

Total Liabilities

$32.8B

Stockholders' Equity

$7.9B

Cash & Equivalents

$3.6B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17.3B	$16.5B	+4.3%
Gross Profit	$8.9B	$8.1B	+10.9%
Operating Income	$2.2B	-$303M	+811.9%
Net Income	$1.4B	-$1.6B	+186.0%